๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland flag Poland ยท Delayed Price ยท Currency is PLN
52.00
-0.20 (-0.38%)
Nov 20, 2026, 4:59 PM CET

WSE:CTX Financials Overview

Millions PLN. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.334.6615.8313.29.163.99
Revenue Growth
-56.05%-70.55%19.88%44.15%129.75%-
Gross Profit
2.823.2210.66.97.073.25
Operating Income
-45.78-43.63-38.97-73.02-38.36-32.84
Net Income
-46.35-42-38.43-70.58-35.89-32.57
Earnings Per Share
-7.84-7.61-8.25-15.19-8.61-7.89
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
-10.7239.2675.790.89117.94
Total Debt
-3.585.643.786.958.18
Net Cash (Debt)
-7.1433.6271.9383.94109.76
Net Cash Growth
--78.75%-53.26%-14.31%-23.53%-
Net Cash Per Share
-1.297.2215.4820.1426.59

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--37.32-31.88-52.2-22.95-28.47
Capital Expenditures
--0.21-0.42-3.01-0.89-5.11
Free Cash Flow
--37.53-32.3-55.21-23.84-33.59
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
84.82%68.99%66.95%52.28%77.21%81.41%
Operating Margin
-1376.13%-936.33%-246.24%-553.11%-418.91%-823.88%
Pretax Margin
-1392.19%-901.22%-242.82%-534.25%-391.94%-817.16%
Profit Margin
-1393.00%-901.22%-242.82%-534.69%-391.94%-817.16%
FCF Margin
--805.36%-204.12%-418.22%-260.32%-842.60%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-166.476.856.85--
PS Ratio
99.3085.4212.4634.8472.82186.20